Undergraduate Degree

  • Yale University , 1995 , New Haven , CT

Medical School

  • New York University School of Medicine , 2000 , New York , NY


  • Children's Hospital of Philadelphia , 2001 , Philadelphia , PA


  • Children's Hospital of New York, Columbia Presbyterian Medical Center , 2003 , New York , NY


  • Boston Children's Hospital , 2008 , Boston , MA


  • American Board of Allergy and Immunology


Publications powered by Harvard Catalyst Profiles

  1. Comparison of 2 delivery vehicles for viscous budesonide to treat eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr. 2014 Sep; 59(3):317-20. View abstract
  2. Creating a new community of support for students with food allergies. NASN Sch Nurse. 2012 Sep; 27(5):260-6. View abstract
  3. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency. J Allergy Clin Immunol. 2010 Dec; 126(6):1234-41.e2. View abstract
  4. The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function. Blood. 2009 Sep 10; 114(11):2254-62. View abstract
  5. Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells. J Allergy Clin Immunol. 2009 Jun; 123(6):1277-86.e5. View abstract
  6. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency. Curr Opin Allergy Clin Immunol. 2008 Dec; 8(6):520-6. View abstract
  7. Children's Hospital Profile. View abstract